Local biotech firm Avivagen hit a snag in revenues this past quarter even as the firm continues to secure regulatory approvals for its alternative to antibiotic-based livestock feed
An Ottawa-based biotech firm that makes a line of natural health products designed to replace antibiotics in livestock feed has announced a multimillion-dollar funding round it says will
Avivagen CEO Cameron Groome was sounding an upbeat tone Friday morning after his company announced it had secured $3.6 million in new funding in a private placement.